In addition to new ways in which energy is being produced, there is a push for new ways in which to store this energy, which may present opportunities in the renewable energy space.
Mewburn Ellis LLP
Located on St John’s Innovation Park, our Cambridge office serves clients from Cambridge and around the world. We cover the full range of intellectual property issues: patents, trade marks, designs, industrial copyright and related matters, in all fields of technology.
Telephone: +44 (0)1223 420 383
Address :
The Maurice Wilkes Building St John’s Innovation Park Cambridge
Post Code: CB4 0DS
Country: United Kingdom
Website: http://www.mewburn.com
Membership Type: Corporate 21-50
Please contact us for advice on any legal or commercial matter relating to intellectual property. Our areas of expertise include:
- advising on patentability and patenting strategy
- drafting and prosecuting patent applications in the UK and Europe
- handing patent oppositions and appeals at the European Patent Office
- advising on, filing, obtaining and defending trade marks and registered designs
- performing IP searching, due diligence and IP reports, including opinions on freedom to operate
- conducting "IP Audits" for businesses funded by partner schemes of the UK Intellectual Property Office, including GrowthAccelerator
- managing international portfolios of intellectual property rights
- advising on infringement of IP rights, including patents, trade marks, (registered and unregistered), designs (registered and unregistered) and copyright, and helping our clients to defend infringement proceedings brought against them
- dealing with other disputes relating to intellectual property, including pre-litigation contentious matters and preparing and advising on settlement agreements, providing litigation support and conducting patent litigation
- establishing entitlements to inventions, designs, copyright and trade marks including preparing any documents necessary to put in place an unbroken chain of title
- advising on and preparing documents relating to technology transfer, including assignment and licensing of patents, designs, copyright and know-how, trade secrets and confidential information; and
- recording assignments, licences and name changes in relation to intellectual property in jurisdictions throughout the world.
We cover all technical fields, including biotechnology & life sciences, pharmaceuticals, chemistry, computers and software, electronics and mechanical engineering.
There are no Products & Services to display
05-04-2021
This article focuses on anticipated innovation in relation to cell culture for the production of cultured meat products.
16-09-2020
While the world waits for a vaccine to be developed and approved for use against the COVID-19 virus, the best measure to identify, slow and prevent the spread of the virus is to test.
30-07-2020
Manufacturers are taking advantage of graphene’s antimicrobial, antistatic and electrically conductive properties to develop face masks.
20-05-2020
Encouraging progress is being made towards vaccine development against Covid-19. It is essential that we continue to incentivise and fund research into and development of these technologies.
06-04-2020
There are still hurdles to the complete commercial availability of viable Li-S batteries, but at the current pace of research a sulfur-powered world could be a real possibility before the decade is out.
11-03-2020
The EU Withdrawal Agreement was ratified by both the UK and the EU Parliaments and therefore at 11 pm UK time on 31 January 2020, the UK left the EU. The Agreement provides for a transition period until 31 December 2020 during which there will be no change to the law or practice of the law.
24-02-2020
Early-stage biotech companies are often founded based on the exciting results of pre-clinical research relating to a new product or treatment. However, due to the need for refinement/development and the extensive work required to demonstrate safety and efficacy in order to obtain regulatory approval, early-stage biotech companies are often a long way away from bringing a new drug or therapy to...
20-12-2018
Massive social, economic and technology trends are converging to change mobility - how we move things from point A to point B, whether that is people, goods or containers. All of these drivers of change are self-reinforcing.
19-12-2018
Cadbury has been dealt a blow by the Court of Appeal in its battle to maintain its trade mark for the colour purple which it uses across all of its chocolate bars. On 5 December 2018 the Court of Appeal confirmed the previous decisions of the UK Intellectual Property Office and the High Court, and refused to accept that Cadbury’s registration is for a series of two different marks.
18-12-2018
In recent years, we have witnessed a remarkable healthcare revolution. Thanks to advances in genetic analysis, molecular biology and cell science, we now know more about the human condition than ever before. This wealth of information opens the door for the next revolution in medicine – treatments that are truly bespoke for each patient.
17-12-2018
A further step towards a withdrawal agreement between the UK and EU27 occurred on 14 November 2018 with the publication of the fully negotiated version of the draft withdrawal agreement by the European Commission.
04-12-2018
The UK Supreme Court issued its decision today on the Warner Lambert vs Generics (UK) Ltd t/a Mylan. The decision concerns Swiss-form patent claims that relate to a specified medical use of a known pharmaceutical compound, in this case the use of pregabalin to treat pain. Nick Sutcliffe of Mewburn Ellis comments.
03-12-2018
The Cambridge office of Mewburn Ellis LLP moved on 26 November to the prestigious St John’s Innovation Park at the centre of the North Cambridge Research and Development Cluster, as the firm continues to expand.
28-11-2018
The UK government announced this week that the UK will proceed with its preparations to ratify the Unified Patent Court Agreement (UPCA).
29-11-2016
European Patent Office (EPO) Guidelines on the evidence required to transfer European applications have changed.
21-11-2016
The UK Intellectual Property Office has just issued a guide to the implications of Brexit for IP rights owned by UK companies. While copyright and both UK and European patents are likely to be unaffected, the uncertainty with respect to EU Trade Marks (EUTM), Registered Community Designs (RCD) and the Unified Patent Court remains to be resolved.
04-08-2016
Reform of the law on unjustified threats of infringement of intellectual property rights will be enacted in this Parliament, reports Mewburn Ellis LLP.
20-05-2016
One of Cambridge-based patent law firm Mewburn Ellis LLP's clients, Mitsui Chemicals, has been named by Thomson Reuters (New York, USA) as one of the top global 100 innovators in 2015.
24-12-2015
One of Cambridge-based IP firm Mewburn Ellis LLP's clients, Alliance Pharmaceuticals plc, have announced their acquisition of the Healthcare Products Business from Sinclair IS Pharma plc.
24-12-2015
Pages
There are no events to display
There are no jobs to display
No Blog articles found
